Indirect Coombs Test - ICT

Indirect Coombs Test – ICT

The Indirect Coombs Test – ICT also known as the Indirect Antiglobulin Test (IAT) is done to detect antibodies that may react against red blood cells. This test plays a crucial role for pregnant women and pre-transfusions screening, ensuring blood compatibility to stop severe immune reactions.

Indirect Coombs Test (ICT)

The test evaluates whether the body has developed antibodies targeting Rh-positive blood cells. 

A positive ICT result indicates:

• The presence of antibodies which specifically attack red blood cells.
• The test evaluates Rh incompatibility between mother and baby during pregnancy.
• A potential for hemolytic transfusion reactions if incompatible blood is used.

The Indirect Coombs Test – ICT is commonly recommended for:

• The test is suggested for Rh-negative pregnant women.
• Patients scheduled for blood transfusions, to ensure donor-receipient incompatibility.
• Individuals receiving organ transplants and hematological treatments.

Identifying Rh antibodies is vital to prevent the development of both hemolytic disease of the newborn (HDN) and  ensure safe transfusion practices.

The Indirect Coombs Test – ICT gives important information about patient immune responses to ensure both safe pregnancies and transfusion safety.

Schedule appointment for the Indirect Coombs Test at UniQ Pathlab

At UniQ Pathlab, we offer precise ICT testing with free home sample collection, expert analysis, and same-day reports—supporting informed and secure medical care for every individual.